Table 1. Comparison of the groups in terms of clinical and admission medications parameters .
| Group with POAF (n=15) | Group with non-POAF (n=75) | P | |
| Age (y), ( ± SD) | 59.1 ± 5.4 | 58.4 ± 9.1 | 0.659 |
| Gender (female), n (%) | 5 (33) | 15 (33) | 0.313 |
| Smoking (pocket/year) ( ± SD) | 19.0 ± 22.1 | 21.0 ± 20.7 | 0.740 |
| Alcohol consumption (n, %) | 0 (0) | 3 (4) | 0.575 |
| BSA ( ± SD) | 1.9 ± 0.1 | 1.9 ± 0.2 | 0.567 |
| DM, n (%) | 10 (66) | 35 (46.6) | 0.157 |
| HT, n (%) | 11 (73.3) | 32 (42.6) | 0.029a |
| COPD, n (%) | 0 (0) | 13 (17.3) | 0.115 |
| ACEi use, n (%) | 7 (46.6) | 35 (46.6) | 0.613 |
| Beta blocker use, n (%) | 10 (66.6) | 55 (73.3) | 0.753 |
| Calcium channel blocker, n (%) | 7 (46.6) | 24 (32) | 0.373 |
| Statin use, n (%) | 13 (86.6) | 57 (76) | 0.506 |
Abbreviations: ACEi, angiotensin converting enzym; BSA, body surface area; CCB, calcium channel bloker; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HT, hypertension; POAF, postoperative atrial fibrilation; SD, standard deviation.
a Statistically significant.